India Perspective

Lower R&D costs, strategic plans for clinical trials, future commercialization with companies in the US and EUROPE, a solid foundation in scientific intellectual capital and technical framework ensuring world class quality standards have already given the Indian pharmaceutical companies a head start over their global counterparts.

Opportunities in this segment are very evident from the facts below: